XML 29 R14.htm IDEA: XBRL DOCUMENT v2.4.0.6
GOING CONCERN
6 Months Ended
Mar. 31, 2012
Going Concern [Abstract]  
GOING CONCERN
NOTE I - GOING CONCERN
 
The accompanying unaudited condensed consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. As shown in the accompanying unaudited condensed consolidated financial statements at March 31, 2012, the Company incurred a net loss for the six month period ended March 31, 2012 of approximately $4.0 million and has an accumulated deficit of $166 million. These factors among others may indicate that the Company will be unable to continue as a going concern for a reasonable period of time.
 
The Company’s existence is dependent upon management’s ability to develop profitable operations. Management is devoting substantially all of its efforts to developing DNA embedded biotechnology security solutions in the United States and Europe and there can be no assurance that the Company’s efforts will be successful and  that management’s actions will result in profitable operations or the resolution of its liquidity problems. The accompanying unaudited condensed consolidated financial statements do not include any adjustments that might result should the Company be unable to continue as a going concern.